|
|
||||||||
The FASEB Journal, Vol 10, 1388-1397, Copyright © 1996 by The Federation of American Societies for Experimental Biology
REVIEWS |
S Spiegel and AH Merrill Jr
Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, D.C. 20007, USA.
Sphingolipids have been implicated in the regulation of cell growth, differentiation, and programmed cell death. The current paradigm for their action is that complex sphingolipids such as gangliosides interact with growth factor receptors, the extracellular matrix, and neighboring cells, whereas the backbones--sphingosine and other long- chain or "sphingoid" bases, ceramides, and sphingosine 1-phosphate-- activate or inhibit protein kinases and phosphatases, ion transporters, and other regulatory machinery. Tumor necrosis factor-alpha, interleukin 1beta, and nerve growth factor, for example, induce sphingomyelin hydrolysis to ceramide. Other agonists, such as platelet- derived growth factor, trigger further hydrolysis of ceramide to sphingosine and activate sphingosine kinase to form sphingosine 1- phosphate. These metabolites either stimulate or inhibit growth and may be cytotoxic (in some cases via induction of apoptosis), depending on which products are formed (or added exogenously), the cellular levels (and possibly intracellular localization), and the cell type. In Swiss 3T3 cells, for example, sphingosine and sphingosine 1-phosphate are growth stimulatory at low concentrations via calcium mobilization from intracellular stores and activation of the mitogen-activated protein kinase (MAP kinase) pathway and transcription factors (AP-1), but are toxic at high concentrations. High levels of endogenous sphingoid bases are also produced by inhibition of ceramide synthase by fumonisins, mycotoxins produced by Fusarium moniliforme, resulting in growth stimulation or toxicity. Thus, sphingolipid metabolites appear to serve as second messengers for growth factors, cytokines, and other "physiological" agonists and, when elevated abnormally, to lead to disease.
This article has been cited by other articles:
![]() |
M. A. Tran, C. D. Smith, M. Kester, and G. P. Robertson Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development Clin. Cancer Res., June 1, 2008; 14(11): 3571 - 3581. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matmati and Y. A. Hannun Thematic Review Series: Sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases J. Lipid Res., May 1, 2008; 49(5): 922 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hatch, Y. Gu, F. Y. Xu, J. Cizeau, S. Neumann, J.-S. Park, S. Loewen, and M. R.A. Mowat StARD13(Dlc-2) RhoGap Mediates Ceramide Activation of Phosphatidylglycerolphosphate Synthase and Drug Response in Chinese Hamster Ovary Cells Mol. Biol. Cell, March 1, 2008; 19(3): 1083 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Coll, A. Morales, J. C. Fernandez-Checa, and C. Garcia-Ruiz Neutral sphingomyelinase-induced ceramide triggers germinal vesicle breakdown and oxidant-dependent apoptosis in Xenopus laevis oocytes J. Lipid Res., September 1, 2007; 48(9): 1924 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jung, M. Hollmann, and M. A. Schafer The fatty acid elongase NOA is necessary for viability and has a somatic role in Drosophila sperm development J. Cell Sci., August 15, 2007; 120(16): 2924 - 2934. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikushiro, M. M. Islam, H. Tojo, and H. Hayashi Molecular Characterization of Membrane-Associated Soluble Serine Palmitoyltransferases from Sphingobacterium multivorum and Bdellovibrio stolpii J. Bacteriol., August 1, 2007; 189(15): 5749 - 5761. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imamura, H. Kusano, Y. Kajigaya, M. Ichikawa, and H. Shimada A Rice Dihydrosphingosine C4 Hydroxylase (DSH1) Gene, which is Abundantly Expressed in the Stigmas, Vascular Cells and Apical Meristem, may be Involved in Fertility Plant Cell Physiol., August 1, 2007; 48(8): 1108 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Eliyahu, J.-H. Park, N. Shtraizent, X. He, and E. H. Schuchman Acid ceramidase is a novel factor required for early embryo survival FASEB J, May 1, 2007; 21(7): 1403 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Anzulovich, A. Mir, M. Brewer, G. Ferreyra, C. Vinson, and R. Baler Elovl3: a model gene to dissect homeostatic links between the circadian clock and nutritional status J. Lipid Res., December 1, 2006; 47(12): 2690 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kohno, M. Momoi, M. L. Oo, J.-H. Paik, Y.-M. Lee, K. Venkataraman, Y. Ai, A. P. Ristimaki, H. Fyrst, H. Sano, et al. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol., October 1, 2006; 26(19): 7211 - 7223. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Watson Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Lipidomics: a global approach to lipid analysis in biological systems J. Lipid Res., October 1, 2006; 47(10): 2101 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dragusin, S. Wehner, S. Kelly, E. Wang, A. H. Merrill Jr., J. C. Kalff, and G. van Echten-Deckert Effects of sphingosine-1-phosphate and ceramide-1-phosphate on rat intestinal smooth muscle cells: implications for postoperative ileus FASEB J, September 1, 2006; 20(11): 1930 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Jin and J. S. Karliner Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKC{varepsilon} dependent mechanism Cardiovasc Res, September 1, 2006; 71(4): 725 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mitsutake and Y. Igarashi Calmodulin Is Involved in the Ca2+-dependent Activation of Ceramide Kinase as a Calcium Sensor J. Biol. Chem., December 9, 2005; 280(49): 40436 - 40441. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Wu, C.-N. Chen, C. I. Lin, J. H. Chen, and H. Lee Lysophospholipids Enhance Matrix Metalloproteinase-2 Expression in Human Endothelial Cells Endocrinology, August 1, 2005; 146(8): 3387 - 3400. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu, J. Zhou, D. M. McCoy, and R. K. Mallampalli LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia J. Lipid Res., June 1, 2005; 46(6): 1229 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Stover, A. Sharma, G. P. Robertson, and M. Kester Systemic Delivery of Liposomal Short-Chain Ceramide Limits Solid Tumor Growth in Murine Models of Breast Adenocarcinoma Clin. Cancer Res., May 1, 2005; 11(9): 3465 - 3474. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hu, R. Xu, G. Zhang, J. Jin, Z. M. Szulc, J. Bielawski, Y. A. Hannun, L. M. Obeid, and C. Mao Golgi Fragmentation Is Associated with Ceramide-induced Cellular Effects Mol. Biol. Cell, March 1, 2005; 16(3): 1555 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Taguchi, T. Kondo, M. Watanabe, M. Miyaji, H. Umehara, Y. Kozutsumi, and T. Okazaki Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase Blood, November 15, 2004; 104(10): 3285 - 3293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C.D. van IJzendoorn, J. M. van der Wouden, G. Liebisch, G. Schmitz, and D. Hoekstra Polarized Membrane Traffic and Cell Polarity Development Is Dependent on Dihydroceramide Synthase-Regulated Sphinganine Turnover Mol. Biol. Cell, September 1, 2004; 15(9): 4115 - 4124. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Geoffroy, N. Wiernsperger, M. Lagarde, and S. El Bawab Bimodal Effect of Advanced Glycation End Products on Mesangial Cell Proliferation Is Mediated by Neutral Ceramidase Regulation and Endogenous Sphingolipids J. Biol. Chem., August 13, 2004; 279(33): 34343 - 34352. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pannu, J.-S. Won, M. Khan, A. K. Singh, and I. Singh A Novel Role of Lactosylceramide in the Regulation of Lipopolysaccharide/Interferon-{gamma}-Mediated Inducible Nitric Oxide Synthase Gene Expression: Implications for Neuroinflammatory Diseases J. Neurosci., June 30, 2004; 24(26): 5942 - 5954. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Worgall, R. A. Juliano, T. Seo, and R. J. Deckelbaum Ceramide Synthesis Correlates with the Posttranscriptional Regulation of the Sterol-Regulatory Element-Binding Protein Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 943 - 948. [Abstract] [Full Text] |
||||
![]() |
T. Tanimoto, A. O. Lungu, and B. C. Berk Sphingosine 1-Phosphate Transactivates the Platelet-Derived Growth Factor {beta} Receptor and Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells Circ. Res., April 30, 2004; 94(8): 1050 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mitsutake, T.-J. Kim, Y. Inagaki, M. Kato, T. Yamashita, and Y. Igarashi Ceramide Kinase Is a Mediator of Calcium-dependent Degranulation in Mast Cells J. Biol. Chem., April 23, 2004; 279(17): 17570 - 17577. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Saba and T. Hla Point-Counterpoint of Sphingosine 1-Phosphate Metabolism Circ. Res., April 2, 2004; 94(6): 724 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Otala, L. Suomalainen, M. O. Pentikainen, P. Kovanen, M. Tenhunen, K. Erkkila, J. Toppari, and L. Dunkel Protection from Radiation-Induced Male Germ Cell Loss by Sphingosine-1-Phosphate Biol Reprod, March 1, 2004; 70(3): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-T. Lee, J. Xu, J.-M. Lee, G. Ku, X. Han, D.-I Yang, S. Chen, and C. Y. Hsu Amyloid-{beta} peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway J. Cell Biol., January 5, 2004; 164(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sanchez, T. Estrada-Hernandez, J.-H. Paik, M.-T. Wu, K. Venkataraman, V. Brinkmann, K. Claffey, and T. Hla Phosphorylation and Action of the Immunomodulator FTY720 Inhibits Vascular Endothelial Cell Growth Factor-induced Vascular Permeability J. Biol. Chem., November 21, 2003; 278(47): 47281 - 47290. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Suomalainen, J. K. Hakala, V. Pentikainen, M. Otala, K. Erkkila, M. O. Pentikainen, and L. Dunkel Sphingosine-1-Phosphate in Inhibition of Male Germ Cell Apoptosis in the Human Testis J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5572 - 5579. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stover and M. Kester Liposomal Delivery Enhances Short-Chain Ceramide-Induced Apoptosis of Breast Cancer Cells J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 468 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Einicker-Lamas, L. D. Wenceslau, R. R. Bernardo, L. Nogaroli, A. Guilherme, M. M. Oliveira, and A. Vieyra Sphingosine-1-Phosphate Formation Activates Phosphatidylinositol-4 Kinase in Basolateral Membranes from Kidney Cells: Crosstalk in Cell Signaling through Sphingolipids and Phospholipids J. Biochem., October 1, 2003; 134(4): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurita-Ochiai, S. Amano, K. Fukushima, and K. Ochiai Cellular Events Involved in Butyric Acid-Induced T Cell Apoptosis J. Immunol., October 1, 2003; 171(7): 3576 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dragusin, C. Gurgui, G. Schwarzmann, J. Hoernschemeyer, and G. van Echten-Deckert Metabolism of the unnatural anticancer lipid safingol, L-threo-dihydrosphingosine, in cultured cells J. Lipid Res., September 1, 2003; 44(9): 1772 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sugawara, M. Kinoshita, M. Ohnishi, J. Nagata, and M. Saito Digestion of Maize Sphingolipids in Rats and Uptake of Sphingadienine by Caco-2 Cells J. Nutr., September 1, 2003; 133(9): 2777 - 2782. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. PETTUS, J. BIELAWSKI, A. M. PORCELLI, D. L. REAMES, K. R. JOHNSON, J. MORROW, C. E. CHALFANT, L. M. OBEID, and Y. A. HANNUN The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-{alpha} FASEB J, August 1, 2003; 17(11): 1411 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Yopp, G. J. Randolph, and J. S. Bromberg Leukotrienes, Sphingolipids, and Leukocyte Trafficking J. Immunol., July 1, 2003; 171(1): 5 - 10. [Full Text] [PDF] |
||||
![]() |
K. Uehara, S. Miura, T. Takeuchi, T. Taki, M. Nakashita, M. Adachi, T. Inamura, T. Ogawa, Y. Akiba, H. Suzuki, et al. Significant Role of Ceramide Pathway in Experimental Gastric Ulcer Formation in Rats J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 232 - 239. [Abstract] [Full Text] |
||||
![]() |
J. Peguet-Navarro, M. Sportouch, I. Popa, O. Berthier, D. Schmitt, and J. Portoukalian Gangliosides from Human Melanoma Tumors Impair Dendritic Cell Differentiation from Monocytes and Induce Their Apoptosis J. Immunol., April 1, 2003; 170(7): 3488 - 3494. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seko, N. Dohmae, K. Takio, and K. Yamashita beta 1,4-Galactosyltransferase (beta 4GalT)-IV Is Specific for GlcNAc 6-O-Sulfate. beta 4GalT-IV ACTS ON KERATAN SULFATE-RELATED GLYCANS AND A PRECURSOR GLYCAN OF 6-SULFOSIALYL-LEWIS X J. Biol. Chem., March 7, 2003; 278(11): 9150 - 9158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Bae, J.-H. Sohn, C.-S. Park, J.-S. Rhee, and E.-S. Choi Integrative Transformation System for the Metabolic Engineering of the Sphingoid Base-Producing Yeast Pichia ciferrii Appl. Envir. Microbiol., February 1, 2003; 69(2): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Florio, S. Arena, A. Pattarozzi, S. Thellung, A. Corsaro, V. Villa, A. Massa, F. Diana, G. Spoto, S. Forcella, et al. Basic Fibroblast Growth Factor Activates Endothelial Nitric-Oxide Synthase in CHO-K1 Cells via the Activation of Ceramide Synthesis Mol. Pharmacol., February 1, 2003; 63(2): 297 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hinkovska-Galcheva, L. Boxer, P. J. Mansfield, A. D. Schreiber, and J. A. Shayman Enhanced Phagocytosis through Inhibition of de Novo Ceramide Synthesis J. Biol. Chem., January 3, 2003; 278(2): 974 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nanjundan and F. Possmayer Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L1 - L23. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Auge, V. Garcia, F. Maupas-Schwalm, T. Levade, R. Salvayre, and A. Negre-Salvayre Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor/PI-3 Kinase/Akt and the Sphingolipid Signaling Pathways Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1990 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sirkar and S. Majumdar Lipoarabinomannan-Induced Cell Signaling Involves Ceramide and Mitogen-Activated Protein Kinase Clin. Vaccine Immunol., November 1, 2002; 9(6): 1175 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Martin, M. Salinas, N. Fujita, T. Tsuruo, and A. Cuadrado Ceramide and Reactive Oxygen Species Generated by H2O2 Induce Caspase-3-independent Degradation of Akt/Protein Kinase B J. Biol. Chem., November 1, 2002; 277(45): 42943 - 42952. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. GOUNI-BERTHOLD and A. SACHINIDIS Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? FASEB J, October 1, 2002; 16(12): 1477 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Venkataraman, C. Riebeling, J. Bodennec, H. Riezman, J. C. Allegood, M. C. Sullards, A. H. Merrill Jr., and A. H. Futerman Upstream of Growth and Differentiation Factor 1 (uog1), a Mammalian Homolog of the Yeast Longevity Assurance Gene 1 (LAG1), Regulates N-Stearoyl-sphinganine (C18-(Dihydro)ceramide) Synthesis in a Fumonisin B1-independent Manner in Mammalian Cells J. Biol. Chem., September 13, 2002; 277(38): 35642 - 35649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kihara and Y. Igarashi Identification and Characterization of a Saccharomyces cerevisiae Gene, RSB1, Involved in Sphingoid Long-chain Base Release J. Biol. Chem., August 9, 2002; 277(33): 30048 - 30054. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gennero, J. Fauvel, M. Nieto, C. Cariven, F. Gaits, F. Briand-Mesange, H. Chap, and J. P. Salles Apoptotic Effect of Sphingosine 1-Phosphate and Increased Sphingosine 1-Phosphate Hydrolysis on Mesangial Cells Cultured at Low Cell Density J. Biol. Chem., April 5, 2002; 277(15): 12724 - 12734. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hanafusa, Y. Yatomi, K. Yamada, Y. Hori, M. Nangaku, T. Okuda, T. Fujita, K. Kurokawa, and M. Fukagawa Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells Nephrol. Dial. Transplant., April 1, 2002; 17(4): 580 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Le Stunff, C. Peterson, R. Thornton, S. Milstien, S. M. Mandala, and S. Spiegel Characterization of Murine Sphingosine-1-phosphate Phosphohydrolase J. Biol. Chem., March 8, 2002; 277(11): 8920 - 8927. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Bourbon, L. Sandirasegarane, and M. Kester Ceramide-induced Inhibition of Akt Is Mediated through Protein Kinase Czeta . IMPLICATIONS FOR GROWTH ARREST J. Biol. Chem., January 25, 2002; 277(5): 3286 - 3292. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hla, M.-J. Lee, N. Ancellin, J. H. Paik, and M. J. Kluk Lysophospholipids--Receptor Revelations Science, November 30, 2001; 294(5548): 1875 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology Circ. Res., November 23, 2001; 89(11): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yasuda, H. Kitagawa, M. Ueno, H. Ishitani, M. Fukasawa, M. Nishijima, S. Kobayashi, and K. Hanada A Novel Inhibitor of Ceramide Trafficking from the Endoplasmic Reticulum to the Site of Sphingomyelin Synthesis J. Biol. Chem., November 16, 2001; 276(47): 43994 - 44002. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gouni-Berthold, C. Seul, Y. Ko, J. Hescheler, and A. Sachinidis Gangliosides GM1 and GM2 Induce Vascular Smooth Muscle Cell Proliferation via Extracellular Signal-Regulated Kinase 1/2 Pathway Hypertension, November 1, 2001; 38(5): 1030 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Abnet, C. B. Borkowf, Y.-L. Qiao, P. S. Albert, E. Wang, A. H. Merrill Jr., S. D. Mark, Z.-W. Dong, P. R. Taylor, and S. M. Dawsey A Cross-Sectional Study of Human Serum Sphingolipids, Diet and Physiologic Parameters J. Nutr., October 1, 2001; 131(10): 2748 - 2752. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Schmelz, P. C. Roberts, E. M. Kustin, L. A. Lemonnier, M. C. Sullards, D. L. Dillehay, and A. H. Merrill Jr. Modulation of Intracellular {beta}-Catenin Localization and Intestinal Tumorigenesis in Vivo and in Vitro by Sphingolipids Cancer Res., September 1, 2001; 61(18): 6723 - 6729. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Senchenkov, D. A. Litvak, and M. C. Cabot Targeting Ceramide Metabolism--a Strategy for Overcoming Drug Resistance J Natl Cancer Inst, March 7, 2001; 93(5): 347 - 357. [Abstract] |